Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Chevron Corporation stock logo
CVX
Chevron
$154.10
+0.7%
$141.92
$132.04
$168.96
$268.94B0.838.33 million shs5.12 million shs
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$157.73
+0.9%
$153.67
$140.68
$169.99
$379.91B0.418.04 million shs3.47 million shs
Pfizer Inc. stock logo
PFE
Pfizer
$25.88
+1.2%
$23.82
$20.92
$31.54
$147.28B0.5841.73 million shs21.66 million shs
Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Chevron Corporation stock logo
CVX
Chevron
+0.13%+3.60%+8.87%+13.61%+0.16%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
+0.20%+0.31%+0.57%+5.01%+6.13%
Pfizer Inc. stock logo
PFE
Pfizer
-0.20%+0.95%+6.65%+18.51%-7.78%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Chevron Corporation stock logo
CVX
Chevron
4.533 of 5 stars
2.13.04.20.03.41.73.1
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
4.8367 of 5 stars
2.35.04.23.93.01.71.9
Pfizer Inc. stock logo
PFE
Pfizer
4.9785 of 5 stars
3.23.04.24.53.31.73.1
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Chevron Corporation stock logo
CVX
Chevron
2.26
Hold$160.654.25% Upside
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
2.55
Moderate Buy$171.008.41% Upside
Pfizer Inc. stock logo
PFE
Pfizer
2.45
Hold$28.5510.34% Upside

Current Analyst Ratings Breakdown

Latest CVX, JNJ, and PFE Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/10/2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingUnderperform ➝ Underperform
7/10/2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$169.00 ➝ $171.00
7/7/2025
Chevron Corporation stock logo
CVX
Chevron
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$152.00 ➝ $156.00
7/2/2025
Chevron Corporation stock logo
CVX
Chevron
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$162.00 ➝ $164.00
6/26/2025
Chevron Corporation stock logo
CVX
Chevron
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$164.00 ➝ $165.00
6/5/2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$181.00
5/29/2025
Pfizer Inc. stock logo
PFE
Pfizer
Berenberg Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHold$28.00 ➝ $25.00
5/21/2025
Pfizer Inc. stock logo
PFE
Pfizer
Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy$32.00 ➝ $33.00
5/19/2025
Pfizer Inc. stock logo
PFE
Pfizer
HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy$27.00 ➝ $26.00
5/13/2025
Chevron Corporation stock logo
CVX
Chevron
Hsbc Global Res
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
5/13/2025
Chevron Corporation stock logo
CVX
Chevron
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$173.00 ➝ $162.00
(Data available from 7/10/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Chevron Corporation stock logo
CVX
Chevron
$192.94B1.39$19.88 per share7.75$85.22 per share1.81
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$88.82B4.27$13.29 per share11.87$29.69 per share5.31
Pfizer Inc. stock logo
PFE
Pfizer
$63.63B2.31$4.41 per share5.87$15.62 per share1.66
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Chevron Corporation stock logo
CVX
Chevron
$17.66B$8.7517.6012.242.647.76%10.73%6.45%8/1/2025 (Estimated)
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$14.07B$8.9917.5614.252.3624.42%33.46%13.30%7/16/2025 (Estimated)
Pfizer Inc. stock logo
PFE
Pfizer
$8.03B$1.3818.778.540.9312.62%20.33%8.53%8/5/2025 (Estimated)

Latest CVX, JNJ, and PFE Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/5/2025Q2 2025
Pfizer Inc. stock logo
PFE
Pfizer
$0.57N/AN/AN/A$13.43 billionN/A
8/1/2025Q2 2025
Chevron Corporation stock logo
CVX
Chevron
$1.58N/AN/AN/A$44.59 billionN/A
7/16/2025Q2 2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$2.65N/AN/AN/A$22.85 billionN/A
5/2/2025Q1 2025
Chevron Corporation stock logo
CVX
Chevron
$2.15$2.18+$0.03$2.00$49.05 billion$47.61 billion
4/29/2025Q1 2025
Pfizer Inc. stock logo
PFE
Pfizer
$0.67$0.92+$0.25$0.52$14.43 billion$13.72 billion
4/15/2025Q1 2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$2.59$2.77+$0.18$4.54$21.65 billion$21.89 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Chevron Corporation stock logo
CVX
Chevron
$6.844.44%N/A78.17%38 Years
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$5.203.30%N/A57.84%64 Years
Pfizer Inc. stock logo
PFE
Pfizer
$1.726.65%N/A124.64%16 Years

Latest CVX, JNJ, and PFE Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
6/25/2025
Pfizer Inc. stock logo
PFE
Pfizer
quarterly$0.437.08%7/25/20257/25/20259/2/2025
4/23/2025
Pfizer Inc. stock logo
PFE
Pfizer
quarterly$0.437.69%5/9/20255/9/20256/13/2025
5/2/2025
Chevron Corporation stock logo
CVX
Chevron
quarterly$1.715.02%5/19/20255/19/20256/10/2025
4/15/2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
quarterly$1.303.37%5/27/20255/27/20256/10/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Chevron Corporation stock logo
CVX
Chevron
0.17
1.08
0.82
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.49
1.26
1.03
Pfizer Inc. stock logo
PFE
Pfizer
0.64
1.26
0.96

Institutional Ownership

CompanyInstitutional Ownership
Chevron Corporation stock logo
CVX
Chevron
72.42%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
69.55%
Pfizer Inc. stock logo
PFE
Pfizer
68.36%

Insider Ownership

CompanyInsider Ownership
Chevron Corporation stock logo
CVX
Chevron
0.21%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.16%
Pfizer Inc. stock logo
PFE
Pfizer
0.06%
CompanyEmployeesShares OutstandingFree FloatOptionable
Chevron Corporation stock logo
CVX
Chevron
45,2981.75 billion1.74 billionOptionable
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
138,1002.41 billion2.40 billionOptionable
Pfizer Inc. stock logo
PFE
Pfizer
81,0005.69 billion5.68 billionOptionable

Recent News About These Companies

Pfizer FY2025 EPS Forecast Decreased by Cantor Fitzgerald
Pfizer Inc. (NYSE:PFE) Shares Sold by Lbp Am Sa

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Chevron stock logo

Chevron NYSE:CVX

$154.10 +1.08 (+0.71%)
As of 02:09 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Chevron Corporation, through its subsidiaries, engages in the integrated energy and chemicals operations in the United States and internationally. The company operates in two segments, Upstream and Downstream. The Upstream segment is involved in the exploration, development, production, and transportation of crude oil and natural gas; processing, liquefaction, transportation, and regasification of liquefied natural gas; transportation of crude oil through pipelines; transportation, storage, and marketing of natural gas; and carbon capture and storage, as well as a gas-to-liquids plant. The Downstream segment refines crude oil into petroleum products; markets crude oil, refined products, and lubricants; manufactures and markets renewable fuels, commodity petrochemicals, plastics for industrial uses, and fuel and lubricant additives; and transports crude oil and refined products by pipeline, marine vessel, motor equipment, and rail car. The company was formerly known as ChevronTexaco Corporation and changed its name to Chevron Corporation in 2005. Chevron Corporation was founded in 1879 and is headquartered in San Ramon, California.

Johnson & Johnson stock logo

Johnson & Johnson NYSE:JNJ

$157.73 +1.45 (+0.93%)
As of 02:09 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Pfizer stock logo

Pfizer NYSE:PFE

$25.88 +0.32 (+1.23%)
As of 02:09 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.